Package 67296-2123-3

Brand: buprenorphine hcl

Generic: buprenorphine hcl
NDC Package

Package Facts

Identity

Package NDC 67296-2123-3
Digits Only 6729621233
Product NDC 67296-2123
Product ID 67296-2123_4698a89b-6565-4e29-e063-6394a90aaf22
Description

30 TABLET in 1 BOTTLE (67296-2123-3)

Marketing

Marketing Status
Marketed Since 2009-10-08
Brand buprenorphine hcl
Generic buprenorphine hcl
Sample Package No

Linked Drug Pages (1)

Buprenorphine HCl ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "4698a89b-6565-4e29-e063-6394a90aaf22", "openfda": {"upc": ["0300540176136"], "unii": ["56W8MW3EN1"], "rxcui": ["351264"], "spl_set_id": ["301eaed5-8499-ad95-e063-6294a90a58f5"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (67296-2123-3)", "package_ndc": "67296-2123-3", "marketing_start_date": "20091008"}], "brand_name": "Buprenorphine HCl", "product_id": "67296-2123_4698a89b-6565-4e29-e063-6394a90aaf22", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "67296-2123", "dea_schedule": "CIII", "generic_name": "Buprenorphine HCl", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine HCl", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA078633", "marketing_category": "ANDA", "marketing_start_date": "20091008", "listing_expiration_date": "20261231"}